Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nazemi

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Neuropathology and Applied Neurobiology|December 9, 2020
Post-treatment hypermutation in a recurrent diffuse glioma with H3.3 p.G34 MutationMatthew D Wood, Tanaya Neff, Joshua P Nickerson, et al.
Journal of Neuro-Oncology|April 25, 2012
Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumorsEric M Thompson, Daniel J Guillaume, Edit Dósa, et al.
Pediatric Blood & Cancer|May 21, 2016
High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702)Kellie J Nazemi, Violet Shen, Jonathan L Finlay, et al.
Nature Neuroscience|March 17, 2009
Proteoglycan interactions with Sonic Hedgehog specify mitogenic responsesJennifer A Chan, Srividya Balasubramanian, Rochelle M Witt, et al.
Technology in Cancer Research & Treatment|December 4, 2003
Instrumentation for multi-modal spectroscopic diagnosis of epithelial dysplasiaJ W Tunnell, A E Desjardins, L Galindo, et al.
Oncotarget|June 12, 2020
Phase I study of vemurafenib in children with recurrent or progressive BRAF<sup>V600E</sup> mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002)Theodore Nicolaides, Kellie J Nazemi, John Crawford, et al.
Cold Spring Harbor Molecular Case Studies|August 25, 2021
Mechanisms of targeted therapy resistance in a pediatric glioma driven by <i>ETV6-NTRK3</i> fusionClare Keddy, Tanaya Neff, Jianya Huan, et al.
Advances in Radiation Oncology|April 14, 2020
Measure Twice: Promise of Liquid Biopsy in Pediatric High-Grade GliomasMatthew S Dietz, Catherine Z Beach, Ramon Barajas, et al.
Developmental Neuroscience|January 20, 2021
The Eya1 Phosphatase Mediates Shh-Driven Symmetric Cell Division of Cerebellar Granule Cell PrecursorsDaniel J Merk, Pengcheng Zhou, Samuel M Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAF<sup>V600E</sup>-Mutant Human GliomaKarisa C Schreck, Andrew Morin, Guisheng Zhao, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Neuropathology and Applied Neurobiology|December 9, 2020
Post-treatment hypermutation in a recurrent diffuse glioma with H3.3 p.G34 MutationMatthew D Wood, Tanaya Neff, Joshua P Nickerson, et al.
Journal of Neuro-Oncology|April 25, 2012
Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumorsEric M Thompson, Daniel J Guillaume, Edit Dósa, et al.
Pediatric Blood & Cancer|May 21, 2016
High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702)Kellie J Nazemi, Violet Shen, Jonathan L Finlay, et al.
Nature Neuroscience|March 17, 2009
Proteoglycan interactions with Sonic Hedgehog specify mitogenic responsesJennifer A Chan, Srividya Balasubramanian, Rochelle M Witt, et al.
Technology in Cancer Research & Treatment|December 4, 2003
Instrumentation for multi-modal spectroscopic diagnosis of epithelial dysplasiaJ W Tunnell, A E Desjardins, L Galindo, et al.
Oncotarget|June 12, 2020
Phase I study of vemurafenib in children with recurrent or progressive BRAF<sup>V600E</sup> mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002)Theodore Nicolaides, Kellie J Nazemi, John Crawford, et al.
Cold Spring Harbor Molecular Case Studies|August 25, 2021
Mechanisms of targeted therapy resistance in a pediatric glioma driven by <i>ETV6-NTRK3</i> fusionClare Keddy, Tanaya Neff, Jianya Huan, et al.
Advances in Radiation Oncology|April 14, 2020
Measure Twice: Promise of Liquid Biopsy in Pediatric High-Grade GliomasMatthew S Dietz, Catherine Z Beach, Ramon Barajas, et al.
Developmental Neuroscience|January 20, 2021
The Eya1 Phosphatase Mediates Shh-Driven Symmetric Cell Division of Cerebellar Granule Cell PrecursorsDaniel J Merk, Pengcheng Zhou, Samuel M Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAF<sup>V600E</sup>-Mutant Human GliomaKarisa C Schreck, Andrew Morin, Guisheng Zhao, et al.
Pageof 3